Valuation: SSY Group Limited

Market Cap 7.43B 948M 846M 782M 708M 1.33B 89.95B 1.35B 9.41B 3.72B 47.13B 3.56B 3.48B 149B P/E 2026 *
12.9x
P/E 2027 * 11.2x
Enterprise Value 7.43B 948M 846M 782M 708M 1.33B 89.95B 1.35B 9.41B 3.72B 47.13B 3.56B 3.48B 149B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.43x
Free-Float
32.72%
Yield 2026 *
4.28%
Yield 2027 * 5.06%
1 day-0.39%
1 week-6.55%
Current month-9.03%
1 month-8.05%
3 months+7.08%
6 months+7.53%
Current year-9.19%
1 week 2.54
Extreme 2.54
2.75
1 month 2.54
Extreme 2.54
2.85
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.18
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
5.68
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 23/03/2010
Director of Finance/CFO 45 01/04/2015
Corporate Officer/Principal 42 28/08/2024
Director TitleAgeSince
Chairman 69 04/06/2014
Director/Board Member 61 26/07/2007
Director/Board Member 57 16/10/2005
Date Insider Type Main position Quantity % Market Cap. Importance
10/2/26 A Other

Chief Executive Officer

500,000 0.0169%
9/29/26 A Other

Chief Executive Officer

1,500,000 0.0508%
9/25/26 A Other

Chief Executive Officer

500,000 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-6.55%-16.56%-37.77% 948M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.64%+1.30%+31.56%+60.03% 400.53B
Weighted average by Cap. -0.26%+2.66%+40.98%+82.10%

Financials

2026 *2027 *
Net sales 4.71B 600M 536M 495M 449M 840M 57B 854M 5.96B 2.36B 29.86B 2.25B 2.21B 94.15B 5.18B 661M 590M 545M 494M 924M 62.71B 939M 6.56B 2.6B 32.86B 2.48B 2.43B 104B
Net income 601M 76.7M 68.49M 63.27M 57.34M 107M 7.28B 109M 761M 301M 3.81B 288M 282M 12.03B 676M 86.25M 77.02M 71.15M 64.48M 121M 8.19B 123M 856M 339M 4.29B 324M 317M 13.52B
Net Debt - -
Projected Income Statement - Annual - SSY Group Limited
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,400
Date Price Change Volume
23/10/26 HK$2.570 -0.39% 3,136,000
22/10/26 HK$2.580 -2.64% 1,420,000
21/10/26 HK$2.650 -1.30% 1,813,117
20/10/26 HK$2.685 -2.36% 1,748,000
16/10/26 HK$2.750 +1.29% 2,308,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - SSY Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.570HKD
Average target price
3.925HKD
Spread / Average Target
+52.72%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - SSY Group Limited
  1. Stock Market
  2. Stocks
  3. 2005 Stock